COVID-19 in Pediatrics

Siobhan Mary Case; Mary Beth Son

doi:10.1016/j.rdc.2021.07.006

COVID-19 in Pediatrics

Rheum Dis Clin North Am. 2021 Nov;47(4):797-811. doi: 10.1016/j.rdc.2021.07.006. Epub 2021 Jul 21.

Authors

Siobhan Mary Case¹, Mary Beth Son²

Affiliations

¹ Division of Immunology, Boston Children's Hospital, 300 Longwood Avenue, Fegan, 6th Floor, Boston, Massachusetts 02115, USA; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, 60 Fenwood Road, 3rd Floor, Boston, MA 02115, USA. Electronic address: siobhan.case@childrens.harvard.edu.
² Division of Immunology, Boston Children's Hospital, 300 Longwood Avenue, Fegan, 6th Floor, Boston, Massachusetts 02115, USA.

Abstract

This article reviews the diagnosis and treatment of infection with severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019, as well as a new inflammatory syndrome after severe acute respiratory syndrome coronavirus 2 infection, called multisystem inflammatory syndrome in children.

Keywords: COVID-19; Coronavirus; Multisystem inflammatory syndrome in children (MIS-C); Pediatric inflammatory multisystem syndrome temporally related to SARS CoV-2 (PIMS-TS).

Publication types

Review

MeSH terms

COVID-19* / complications
Child
Humans
Pediatrics*
SARS-CoV-2
Systemic Inflammatory Response Syndrome

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related